Literature DB >> 3592711

[Clinicopathological study of gastric cancer with bone metastasis].

H Nishidoi, S Koga.   

Abstract

Fifty-eight patients with bone metastasis from gastric cancer, of whom 33 patients were resected cases and 25 were autopsies, were investigated. The incidence of bone metastasis of gastric cancer was 13.4% (33/246) among autopsies and was higher than that (1.5%, 33/2242) among resected cases. We attempted to clarify the factors related to bone metastasis by clinicopathological study. Bone metastasis had a tendency to occur in invasive cancer such as Borrmann types three or four. Histological examination revealed that 86% (50/58) of bone metastasis was poorly differentiated adenocarcinoma and that the stroma was scirrhous type in almost all cases. We measured serum alkaline phosphatase in patients with bone metastasis of recurrent gastric cancer, and found that the levels were relatively related to the condition of bone metastasis. However, the prognosis of patients with bone metastasis was not good and the mean survival time was about 5 months after the appearance of symptoms. In our department, we employ total body hyperthermia in such cases. This method has proved relatively effective for bone metastasis, as reflected by bone scintigram and changes in serum alkaline phosphatase values. As there is no reliable method of treatment for bone metastasis of gastric cancer, the present approach may be worth trying.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3592711

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  17 in total

1.  Bone metastasis in gastric cancer patients.

Authors:  Jae Bong Ahn; Tae Kyung Ha; Sung Joon Kwon
Journal:  J Gastric Cancer       Date:  2011-03-31       Impact factor: 3.720

2.  Bony metastasis of gastric adenocarcinoma.

Authors:  Bhavesh Devkaran; R Jhobta; D K Verma
Journal:  Saudi J Gastroenterol       Date:  2009-04       Impact factor: 2.485

3.  Bone metastasis as the first sign of gastric cancer.

Authors:  Wafa Ben Ameur; Safa Belghali; Imen Akkari; Houneida Zaghouani; Elyes Bouajina; Elhem Ben Jazia
Journal:  Pan Afr Med J       Date:  2017-09-29

4.  Gastric cancer presenting with solitary gigantic pelvic metastasis.

Authors:  Qi Zheng; Kejun Nan; Yu Yao
Journal:  J Biomed Res       Date:  2012-04-15

5.  Compressive myeloradiculopathy from bony metastasis as the initial presentation of poorly differentiated adenocarcinoma stomach - a case report.

Authors:  Aneesh Basheer; Jolly Daniel; Somanath Padhi
Journal:  Australas Med J       Date:  2013-10-31

6.  Bilateral metastasis to the femoral head as the only manifestation of recurrence of gastric adenocarcinoma: a case report.

Authors:  Ma Jesus Fernández-Aceñero; Teresa Aramendi Sánchez
Journal:  World J Surg Oncol       Date:  2003-09-18       Impact factor: 2.754

7.  Distal phalanx: an unusual site for a gastric adenocarcinoma metastasis.

Authors:  Holly Harris; Mansoor Khan; Shameen Jaunoo
Journal:  BMJ Case Rep       Date:  2020-09-09

8.  Vertebral carcinomatosis eleven years after advanced gastric cancer resection: A case report.

Authors:  Francesco Iovino; Michele Orditura; Pasquale Pio Auriemma; Francesca Romana Ciorra; Giovanni Giordano; Consiglia Orabona; Francesco Bara; Renato Sergio; Beatrice Savastano; Alessio Fabozzi; Maria Maddalena Laterza; Jole Ventriglia; Angelica Petrillo; Carminia Maria Della Corte; Ferdinando DE Vita
Journal:  Oncol Lett       Date:  2014-12-23       Impact factor: 2.967

9.  Gastric carcinoma with bone marrow metastasis: a case series.

Authors:  Ahmet Şiyar Ekinci; Oznur Bal; Tahsin Ozatlı; Ibrahim Türker; Onur Eşbah; Ayşe Demirci; Burçin Budakoğlu; Ulkü Yalçıntaş Arslan; Emrah Eraslan; Berna Oksüzoğlu
Journal:  J Gastric Cancer       Date:  2014-03-31       Impact factor: 3.720

10.  Bone metastasis from gastric cancer: the incidence, clinicopathological features, and influence on survival.

Authors:  Fatma Paksoy Turkoz; Mustafa Solak; Saadettin Kilickap; Arife Ulas; Onur Esbah; Berna Oksuzoglu; Suayib Yalcin
Journal:  J Gastric Cancer       Date:  2014-09-30       Impact factor: 3.720

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.